Scribe Biosciences
About Scribe Biosciences
This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.
This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.
What does Scribe Biosciences do?
This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.
Where is Scribe Biosciences located?
Scribe Biosciences is based in San Francisco, United States.
When was Scribe Biosciences founded?
Scribe Biosciences was founded in 2017.
How much funding has Scribe Biosciences raised?
Scribe Biosciences has raised $250.0K.
- Location
- San Francisco, United States
- Founded
- 2017
- Funding
- $250.0K
- Employees
- 3 employees
- Investors
- Formic
